Successful treatment of CD8+ syringotropic mycosis fungoides with bexarotene and local radiotherapy

Dermatol Ther. 2022 Nov;35(11):e15850. doi: 10.1111/dth.15850. Epub 2022 Sep 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Bexarotene / therapeutic use
  • CD8-Positive T-Lymphocytes
  • Humans
  • Mycosis Fungoides* / drug therapy
  • Mycosis Fungoides* / radiotherapy
  • Skin Neoplasms* / drug therapy
  • Skin Neoplasms* / radiotherapy
  • Tetrahydronaphthalenes / therapeutic use

Substances

  • Bexarotene
  • Tetrahydronaphthalenes